Decision: Favourable

Decisions Table

Study Title:

RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 3 TRIAL OF TRIUMEQ IN AMYOTROPHIC LATERAL SCLEROSIS

  • NREC Code:

    22-NREC-CT-153

  • Decision:

    Favourable

  • Study Type:

    NREC CT

  • Principal Investigator:

    Prof Orla Hardiman

  • PI Institution:

    Beaumont Hospital

  • Sponsor:

    Stichting TRICALS Foundation

Scroll to Top